[TechWeb] November 8, Zero Krypton Technology (Tianjin) Co., Ltd. (hereinafter referred to as "Zero Krypton Technology" or "Zero Krypton") and Merck & Co Inc (China) Investment Co., Ltd. (hereinafter referred to as "Merck & Co Inc China") officially signed a memorandum of cooperation, demonstrating their intention to explore innovative ways of cooperation in the fields of patient health management, digital technology and digital pharmaceutical industry, so as to help the implementation of the "healthy China" strategy.
It is understood that the cooperation intention conveyed by Zero Krypton and Merck & Co Inc China means that in the future, the two sides will give full play to their respective advantages in the fields of medicine and health and Internet healthcare, and jointly explore how to better serve patients and the public in the field of "Internet + Medical and Health" in China, so as to contribute to the construction of China's medical ecosystem.
Speaking of this cooperation, Merck & Co Inc, a relevant official in China, said that Merck & Co Inc has always adhered to "putting patients first", actively fighting major global diseases, and providing innovative drugs and vaccines to solve life-threatening diseases and public health threats. At the same time, we also take China's rapidly growing health demand as the core, and join hands with partners such as Zero Krypton to innovate patient empowerment model and build a new healthy ecology of the pharmaceutical industry. actively seize the new opportunities brought about by innovative business models and digitalization.
At the same time, the person in charge of Zero Krypton Technology mentioned that Zero Krypton is committed to "making doctors easy to diagnose, easy to treat and easy to do scientific research, so that patients can have good medicine and good protection", and use the power of data technology and AI to enable high-quality medical services to benefit a wider range of Chinese patients. In the digital medical era, Zero Krypton is also shouldering the responsibility of the innovative subject of the largest lifecycle care platform for cancer patients in China. It is believed that this cooperation will be an important opportunity. With their respective core advantages in innovative drug research and development and Internet medical services, Zero Krypton and Merck & Co Inc will work together to create a digital innovation ecology of the medical industry and promote the deep integration and development of Internet + Medical and Health.
According to the data, Merck & Co Inc China is headquartered in Shanghai, with R & D centers in Beijing and factories in Hangzhou, Ningbo and Tianjin, realizing the integration of R & D, manufacturing and commercial operations.
Founded in 2014, Zero Krypton Technology focuses on major diseases such as tumors and rare diseases, provides big data one-stop solution, and is committed to creating an Internet medical platform that makes doctors easy to diagnose, easy to treat, easy to research, and patients with good medicine and protection. At present, it has a multi-disciplinary professional team of more than 1500 people across "clinical medicine, computer science, drug research and development, artificial intelligence technology, and commercial services". It has built a business network covering 31 provinces and cities across the country, and cooperated with more than 330 hospitals across the country to serve 85 per cent of global TOP20 life sciences companies and Chinese TOP10 pharmaceutical companies, as well as half of the life technology companies listed in Hong Kong.